Nutex Health
NUTX
51 hedge funds and large institutions have $23.6M invested in Nutex Health in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.12% more ownership
Funds ownership: 0% → 1.12% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$13.1M |
| 2 |
Goldman Sachs
New York
|
+$7.89M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.15M |
| 4 |
HRT Financial
New York
|
+$4.84M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.83M |
Top Sellers
NUTX Hedge Fund Activity: Q2 2022 in Review
51 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q2 2022, worth a combined $23.6M.
Buyers outnumbered sellers: 51 funds opened new NUTX positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $13.1M.
- 51 institutional investors held Nutex Health (NUTX) as of Q2 2022, up from 0 in Q1 2022.
- Funds reported $23.6M of Nutex Health stock for Q2 2022.
- 51 funds opened new Nutex Health positions in Q2 2022 and 0 closed out, a net change of +51 holders.
- The largest Nutex Health buyer in Q2 2022 was BlackRock, an estimated $13.1M added.
Based on aggregated 13F filings for Q2 2022.